UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA -Mutated HER2-Positive Metastatic Breast Cancer

Clinical cancer research, 2021-07, Vol.27 (14), p.3867-3875

2021

Volltextzugriff (PDF)

Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia

Breast cancer research and treatment, 2016-06, Vol.157 (2), p.395-400

2016

Volltextzugriff (PDF)

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

Journal of clinical oncology, 2001-05, Vol.19 (10), p.2587-2595

2001

Volltextzugriff (PDF)

Bevacizumab 5 mg/kg Can Be Infused Safely Over 10 Minutes

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2691-2695

2007

Volltextzugriff (PDF)

The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/neu Overexpressed/Amplified Breast Cancer

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1216-1222

2008

Volltextzugriff (PDF)

Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT

American journal of roentgenology (1976), 2000-09, Vol.175 (3), p.795

2000

Volltextzugriff (PDF)

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

Clinical breast cancer, 2018-10, Vol.18 (5), p.387-394

2018

Volltextzugriff (PDF)

Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer

Cancer, 2012-07, Vol.118 (13), p.3254-3259

2012

Volltextzugriff (PDF)

Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents

International journal of gynecological cancer, 2022-06, Vol.32 (8), p.1056-1062

2022

Volltextzugriff (PDF)

NU-16PATIENT SAFETY MAY BE IMPROVED USING A DOSE CALCULATING-AND-ROUNDING ELECTRONIC CHEMOTHERAPY ORDER ENTRY AND VERIFICATION SYSTEM WITH CLINICAL DECISION SUPPORT SYSTEM (CDSS) FEATURES IN THE PEDIATRIC SETTING

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii137.6-iii138

2016

Volltextzugriff (PDF)

Arterial Desaturation Syndrome Following Pleurodesis with Talc Slurry: Incidence, Clinical Features, and Outcome

Cancer investigation, 2003, Vol.21 (6), p.848-854

2003

Volltextzugriff (PDF)

Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.590-590

2015

Volltextzugriff (PDF)

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial

Breast cancer research and treatment, 2001-04, Vol.66 (3), p.239-248

2001

Volltextzugriff (PDF)

Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.607-607

2015

Volltextzugriff (PDF)

Establishing clinical guidelines for the management of acute hypersensitivity reactions secondary to the administration of chemotherapy/biologic therapy

Journal of nursing care quality, 2003-01, Vol.18 (1), p.80-86

2003

Volltextzugriff (PDF)

A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin―Cyclophosphamide (AC) Followed by Nanoparticle Albumin―Bound Paclitaxel in Early-Stage Breast Cancer

Clinical cancer research, 2011-05, Vol.17 (10), p.3398-3407

2011

Volltextzugriff (PDF)

Metastatic placental lymphoma associated with maternal human immunodeficiency virus infection

Obstetrics and gynecology (New York. 1953), 1993-05, Vol.81 (5), p.856-857

1993

Volltextzugriff (PDF)

Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)

Journal of clinical oncology, 2012-09, Vol.30 (27_suppl), p.134-134

2012

Volltextzugriff (PDF)

A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10514-10514

2012

Volltextzugriff (PDF)

Phase I Study of Escalating Doses of Edatrexate in Combination with Paclitaxel in Patients with Metastatic Breast Cancer

Clinical cancer research, 1999-02, Vol.5 (2), p.275-279

1999

Volltextzugriff (PDF)

Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice

Cancer research (Chicago, Ill.), 1988, Vol.48 (1), p.64-67

1988

Volltextzugriff (PDF)

A phase I trial and pharmacokinetic evaluation of CI-980 in patients with advanced solid tumors

Investigational new drugs, 1997-01, Vol.15 (3), p.235-246

1997

Volltextzugriff (PDF)

Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer

Clinical breast cancer, 2010-12, Vol.10 (6), p.440-444

2010

Volltextzugriff (PDF)

Spontaneous recurrent tumor lysis syndrome in breast cancer

American journal of clinical oncology, 1995-02, Vol.18 (1), p.71-73

1995

Volltextzugriff (PDF)

Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a Phase II randomized trial of adjuvant Dose-dense chemotherapy for women with node-positive breast carcinoma

Clinical cancer research, 2001-12, Vol.7 (12), p.3934-3941

2001

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(22)
Middle Aged
(19)
Oncology
(19)
Female
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Adult
(14)
Aged
(11)
Breast Neoplasms - Drug Therapy
(11)
Pharmacology. Drug Treatments
(10)
Antineoplastic Agents
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Chemotherapy
(9)
Tumors
(8)
Breast Neoplasms - Pathology
(7)
Gynecology. Andrology. Obstetrics
(7)
Drug Administration Schedule
(6)
Male
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA -Mutated HER2-Positive Metastatic Breast Cancer

Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

Bevacizumab 5 mg/kg Can Be Infused Safely Over 10 Minutes

The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/neu Overexpressed/Amplified Breast Cancer

Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer

Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents

NU-16PATIENT SAFETY MAY BE IMPROVED USING A DOSE CALCULATING-AND-ROUNDING ELECTRONIC CHEMOTHERAPY ORDER ENTRY AND VERIFICATION SYSTEM WITH CLINICAL DECISION SUPPORT SYSTEM (CDSS) FEATURES IN THE PEDIATRIC SETTING

Arterial Desaturation Syndrome Following Pleurodesis with Talc Slurry: Incidence, Clinical Features, and Outcome

Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial

Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result

Establishing clinical guidelines for the management of acute hypersensitivity reactions secondary to the administration of chemotherapy/biologic therapy

A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin―Cyclophosphamide (AC) Followed by Nanoparticle Albumin―Bound Paclitaxel in Early-Stage Breast Cancer

Metastatic placental lymphoma associated with maternal human immunodeficiency virus infection

Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)

A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)

Phase I Study of Escalating Doses of Edatrexate in Combination with Paclitaxel in Patients with Metastatic Breast Cancer

Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice

A phase I trial and pharmacokinetic evaluation of CI-980 in patients with advanced solid tumors

Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer

Spontaneous recurrent tumor lysis syndrome in breast cancer

Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a Phase II randomized trial of adjuvant Dose-dense chemotherapy for women with node-positive breast carcinoma

Suchergebnisse filtern